The Patent Finder

4SC Discovery GmbH

Also on record
Records under this name other than patents 4SC Discovery GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to 4SC Discovery GmbH

PatentTitleStatus Expires Confidence
US 8,354,436IL17 and Ifn-Gamma Inhibition for the Treatment of Autoimmune Inflammation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,592,456IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,005,7692,3-Dihydrobenzofuran-5YL Compounds as Dyrk Kinase Inhibitors
Formerly held
Lapsed on the fee record
Ended Jun 26, 2026 · High confidence
Lapsed on the fee recordEnded Jun 26, 2026High confidence
US 9,951,050Method of inhibiting DYRK1B
Formerly held
Lapsed on the fee record
Ended Apr 24, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2026From the USPTO record
US 9,580,438Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders
Formerly held
Lapsed on the fee record
Ended Feb 28, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 28, 2025From the USPTO record
US 10,633,369Method of inhibiting DYRK1B
Formerly held
Lapsed on the fee record
Ended Apr 28, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 28, 2024From the USPTO record
US 8,227,516Compounds as histone deacetylase inhibitors
Lapsed on the fee record
Ended Jul 24, 2016 · From the USPTO record
Lapsed on the fee recordEnded Jul 24, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited